No ticker was mentioned, just that it had a market valuation of around $20M with a 3 years and phase 2b trial away from a multi billion dollar valuation.
- Forums
- ASX - By Stock
- PAA
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-822
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $95.68M |
Open | High | Low | Value | Volume |
21.5¢ | 23.0¢ | 21.5¢ | $443.1K | 2.052M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 120200 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 124358 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 120200 | 0.215 |
5 | 281446 | 0.210 |
5 | 324206 | 0.205 |
12 | 449445 | 0.200 |
8 | 267463 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 124358 | 3 |
0.225 | 23500 | 2 |
0.230 | 166203 | 4 |
0.240 | 159752 | 3 |
0.245 | 196127 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online